In order to explore the mechanism of increasing chemotherapeutic drug cisplatin sensitivity from the perspective of the tumor cell metabolism and mitochondrial pathway apoptosis, this study targeted the TIGAR to explore the potential role of p53 and cisplatin in the treatment of lung cancer. This evidence concerns the gene TP53 and lung carcinoma.